Bristol-Myers Squibb Company (NYSE: BMY) has signed a definitive agreement to sell its ConvaTec business unit to Nordic Capital Fund ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE